Clinical Trials Logo

Clinical Trial Summary

Pharmacologic approaches to increase levels or actions of the vasodilatory peptide angiotensin-(1-7) are currently in development for the treatment of hypertension based on findings from animal models. There are limited and contradictory clinical studies, however, and it is not clear if this peptide regulates blood pressure in humans. The purpose of this study is to better understand the cardiovascular effects angiotensin-(1-7) in human hypertension, and to examine interactions of this peptide with the autonomic nervous system. The investigators propose that the difficulties in showing angiotensin-(1-7) cardiovascular effects in previous clinical studies relates to the buffering capacity of the baroreceptor reflex to prevent changes in blood pressure. Autonomic failure provides the ideal patient population to test this hypothesis. These patients have loss of baroreflex buffering and have low levels of angiotensin-(1-7) in blood. The investigators will test if angiotensin-(1-7) infusion can lower blood pressure in patients with autonomic failure, and will determine the hemodynamic and hormonal mechanisms involved in this effect.


Clinical Trial Description

This is an inpatient study that requires at least four days of admission to the Vanderbilt Clinical Research Center. Autonomic failure patients will be placed on a fixed diet during the admission and will have routine tests performed for screening and clinical characterization. Patients will then receive intravenous angiotensin-(1-7) or saline infusion on two separate study days, with each study day lasting approximately 3 hours. There will be at least one washout day between study days. Patients will be instrumented with two intravenous catheters (one for blood sampling and one for drug infusion), arm and finger blood pressure cuffs, and sticky patches to measure heart rate during the study. The investigators will take baseline measurements of blood pressure and heart rate and collect blood samples. The investigators will also perform a rebreathing test to measure the heart's pumping capacity. After baseline measurements, the investigators will infusion angiotensin-(1-7) or saline for 50 minutes. There will be five doses of angiotensin-(1-7). Each dose will be maintained for 10 minutes. The investigators will measure blood pressure and heart rate, repeat the rebreathing test, and collect blood samples at the end of each dosing period. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02591173
Study type Interventional
Source Vanderbilt University Medical Center
Contact
Status Terminated
Phase Early Phase 1
Start date February 2016
Completion date July 2020

See also
  Status Clinical Trial Phase
Completed NCT02705755 - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Phase 2
Recruiting NCT02897063 - Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Phase 1
Recruiting NCT04620382 - Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients Early Phase 1
Terminated NCT01927055 - A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy Phase 3
Completed NCT00775853 - Biomarkers of Risk of Parkinson Disease
Withdrawn NCT01119417 - The Role of Endothelin in the Supine Hypertension of Autonomic Failure Phase 1
Completed NCT01316666 - Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension N/A
Terminated NCT01292694 - Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure Phase 1
Recruiting NCT03482297 - Automated Abdominal Binder for Orthostatic Hypotension Phase 1/Phase 2
Recruiting NCT05489575 - CPAP for the Treatment of Supine Hypertension N/A
Recruiting NCT01799915 - Natural History Study of Synucleinopathies
Terminated NCT01607268 - Magnetic Resonance Spectroscopy in Autonomic Failure N/A
Completed NCT00742586 - Autonomic Failure Patients for RNA Blood Sampling N/A
Completed NCT04700722 - Synuclein-One Study
Recruiting NCT03042988 - Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension N/A
Completed NCT01044693 - Nebivolol in the Supine Hypertension of Autonomic Failure N/A
Recruiting NCT04782830 - Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms N/A
Recruiting NCT04246437 - [18F]F-DOPA Imaging in Patients With Autonomic Failure Phase 1
Completed NCT02640339 - Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease
Completed NCT00178919 - Nitric Oxide and the Autonomic Nervous System N/A